1. Evaluation of manufacturing feasibility and safety of an MDCK cell-based live attenuated influenza vaccine (LAIV) platform. Issue 52 (14th December 2020) Authors: Ganguly, Milan; Yeolekar, Leena; Tyagi, Parikshit; Sagar, Umesh; Narale, Swapnil; Anaspure, Yashodhan; Tupe, Sham; Wadkar, Kuntinath; Ingle, Nilesh; Dhere, Rajeev; Scorza, Francesco B.; Mahmood, Kutub Journal: Vaccine Issue: Volume 38:Issue 52(2020) Page Start: 8379 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗